Neuehealth, INC Form 4 insider transactions

Director Robert Sheehy reports acquisition and disposal of NeueHealth, Inc. stock and restricted stock units.

Director Mohamad Makhzoumi reports acquisition of shares through RSU vesting and adjustments to beneficial ownership following a reverse stock split.

Director Linda Gooden reports acquisition and disposal of NeueHealth, Inc. common stock and restricted stock units.

Director Andrew Slavitt reports changes in beneficial ownership of NeueHealth, Inc. stock, including the vesting of restricted stock units and transactions by related entities.

Director Kedrick D. Adkins Jr. reports acquisition and disposal of NeueHealth, Inc. stock and restricted stock units.

Jeffrey Scherman, Chief Accounting Officer of NeueHealth, Inc., reports the vesting and sale of common stock to cover tax obligations.

Chief Financial Officer of NeueHealth, Jay Matushak, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Jeffrey Scherman, Chief Accounting Officer of NeueHealth, Inc., reports the acquisition of restricted stock units following shareholder approval of an amendment to the company's incentive plan.

NeueHealth's General Counsel and Corporate Secretary, Michael Craig, received grants of restricted stock units after shareholder approval of an amendment to the company's incentive plan.

EVP Tomas Orozco of NeueHealth, Inc. reports the acquisition of restricted stock units following shareholder approval of an amendment to the company's incentive plan.

Chief Financial Officer of NeueHealth, Jay Matushak, reports the acquisition of restricted stock units following shareholder approval of an amendment to the company's incentive plan.

George Lawrence Mikan III, CEO of NeueHealth, received 970,000 restricted stock units after shareholder approval of an amendment to the company's incentive plan.

Rick Yang, a director of NeueHealth, acquired warrants to purchase common stock pursuant to a Warrantholders Agreement.

Paul Edward Walker, a director at NeueHealth, acquired warrants to purchase common stock following a warrantholders agreement.

Scott D. Sandell, a director of NeueHealth, indirectly acquired warrants to purchase common stock following an amendment to the company's credit agreement.

Director Edward Mathers reports acquisition of warrants to purchase NeueHealth, Inc. common stock, pursuant to a Warrantholders Agreement.

Director Mohamad Makhzoumi reports the acquisition of warrants to purchase NeueHealth common stock, issued pursuant to a warrantholders agreement and amendments to a credit agreement.

Anthony A. Florence, Jr., a director at NeueHealth, reported the acquisition of warrants exercisable for common stock, following the company's notification to the NYSE.

Carmen Chang, a director of NeueHealth, acquired warrants to purchase common stock following a warrantholders agreement on April 8, 2024.

Ali Behbahani, a director of NeueHealth, Inc., acquired warrants to purchase common stock as part of a Warrantholders Agreement.

Director Forest Baskett reports the acquisition of warrants for NeueHealth, Inc. through a transaction dated April 8, 2024.

NEA 18 Venture Growth Equity, L.P. reports acquisition of warrants to purchase 371,187 shares of NeueHealth, Inc. common stock.

New Enterprise Associates 17, L.P. reports the acquisition of warrants to purchase 123,729 shares of NeueHealth, Inc. common stock.

New Enterprise Associates 16, L.P. reports acquisition of warrants in NeueHealth, Inc. following a warrantholders agreement.

New Enterprise Associates 15, L.P. reports the acquisition of warrants to purchase 123,729 shares of NeueHealth, Inc. common stock.

Jeffrey J. Scherman, Chief Accounting Officer of NeueHealth, sold 568 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

EVP Tomas Orozco sold 822 shares of NeueHealth stock on March 18, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Jeffery Michael Craig, General Counsel & Corporate Secretary of NeueHealth, Inc., sold 260 shares of common stock on March 18, 2024, to cover tax withholding obligations.

NeueHealth's CFO, Jay Matushak, sold 1,083 shares of common stock on March 18, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

George Lawrence Mikan III, CEO of NeueHealth, sold 4,990 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.